These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19329229)

  • 1. Progressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model.
    Rönnbäck A; Zhu S; Dillner K; Aoki M; Lilius L; Näslund J; Winblad B; Graff C
    Neurobiol Aging; 2011 Feb; 32(2):280-92. PubMed ID: 19329229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid neuropathology in the single Arctic APP transgenic model affects interconnected brain regions.
    Rönnbäck A; Sagelius H; Bergstedt KD; Näslund J; Westermark GT; Winblad B; Graff C
    Neurobiol Aging; 2012 Apr; 33(4):831.e11-9. PubMed ID: 21880397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
    Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
    J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAGE does not affect amyloid pathology in transgenic ArcAbeta mice.
    Vodopivec I; Galichet A; Knobloch M; Bierhaus A; Heizmann CW; Nitsch RM
    Neurodegener Dis; 2009; 6(5-6):270-80. PubMed ID: 20145420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y; López-Ramos JC; Giménez-Llort L; Revilla S; Guerra R; Gruart A; Laferla FM; Cristòfol R; Delgado-García JM; Sanfeliu C
    J Alzheimers Dis; 2011; 24(3):421-54. PubMed ID: 21297257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced brain volumes in mice expressing APP-Austrian mutation but not in mice expressing APP-Swedish-Austrian mutations.
    Van Broeck B; Vanhoutte G; Cuijt I; Pereson S; Joris G; Timmermans JP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurosci Lett; 2008 Dec; 447(2-3):143-7. PubMed ID: 18840503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease.
    Walker JM; Fowler SW; Miller DK; Sun AY; Weisman GA; Wood WG; Sun GY; Simonyi A; Schachtman TR
    Behav Brain Res; 2011 Sep; 222(1):169-75. PubMed ID: 21443906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
    Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
    Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
    Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
    J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
    Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
    Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cognition alteration across the course of the disease in APP751SL mice with parallel estimation of cerebral Abeta deposition.
    Blanchard J; Decorte L; Noguès X; Micheau J
    Behav Brain Res; 2009 Jul; 201(1):147-57. PubMed ID: 19428628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LMN diet, rich in polyphenols and polyunsaturated fatty acids, improves mouse cognitive decline associated with aging and Alzheimer's disease.
    Fernández-Fernández L; Comes G; Bolea I; Valente T; Ruiz J; Murtra P; Ramirez B; Anglés N; Reguant J; Morelló JR; Boada M; Hidalgo J; Escorihuela RM; Unzeta M
    Behav Brain Res; 2012 Mar; 228(2):261-71. PubMed ID: 22119712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
    Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice.
    Knobloch M; Konietzko U; Krebs DC; Nitsch RM
    Neurobiol Aging; 2007 Sep; 28(9):1297-306. PubMed ID: 16876915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BACE/APPV717F double-transgenic mice develop cerebral amyloidosis and inflammation.
    Ozmen L; Woolley M; Albientz A; Miss MT; Nelboeck P; Malherbe P; Czech C; Gruninger-Leitch F; Brockhaus M; Ballard T; Jacobsen H
    Neurodegener Dis; 2005; 2(6):284-98. PubMed ID: 16909011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
    Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
    Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.